000			02844nam a22004095i 4500
710	2		_aSpringerLink (Online service) _9106996
999			_c117101 _d117101 _x1
001			117101
003			ES-MaUEC
005			20230102113809.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			190903s2019 si | s |||| 0|eng d
020			_a9789811357930
024	7		_a10.1007/978-981-13-5793-0 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRA410.55 .J3 _b2019 EB
100	1		_aKamae, Isao _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9672077
245	1	0	_aHealth Technology Assessment in Japan _bPolicy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond _cby Isao Kamae.
250			_a1st ed. 2019.
264		1	_aSingapore _bSpringer Singapore : _bImprint: Adis _c2019.
300			_a1 recurso en línea (XVI, 269 páginas) _b118 ilustraciones, 94 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_a1. Basics to Know -- 2. New HTA Policy in Japan -- 3. MHLW Guideline for Cost-effectiveness Analysis -- 4. How to Appraise -- 5. Exercises for Powerful Assessment -- 6. Intermediate Level Methods -- 7.Advanced Research Topics.
520			_aRepresenting the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan's foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader's expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.
988			_aSpringer_Medicine_2019
650		7	_aEconomía de la salud _zJapón _2embne _9150344
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9789811357923
776	0	8	_iPrinted edition: _z9789811357947
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-5793-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _cm _dz _feng _ggw _h0 _b01/2020 _eIG _zSI